These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29094377)

  • 1. Prognostic significance of the distribution of lymph node metastasis in rectal cancer after neoadjuvant chemoradiation.
    Lee SY; Kim CH; Kim YJ; Kim HR
    J Surg Oncol; 2018 Mar; 117(3):514-522. PubMed ID: 29094377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of the Distribution of Lymph Node Metastasis in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Chen B; Liu X; Zhang Y; Zhuang J; Peng Y; Wang Y; Wu Y; Li S; Yang Y; Guan G
    Front Surg; 2021; 8():749575. PubMed ID: 34869558
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer.
    Huh JW; Kim YJ; Kim HR
    Ann Surg; 2012 Jan; 255(1):70-8. PubMed ID: 22133895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
    Madbouly KM; Abbas KS; Hussein AM
    Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
    Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement.
    Sprenger T; Rothe H; Becker H; Beissbarth T; Homayounfar K; Gauss K; Kitz J; Wolff H; Scheel AH; Ghadimi M; Rödel C; Conradi LC; Liersch T
    Am J Surg Pathol; 2013 Aug; 37(8):1283-9. PubMed ID: 23851331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for low rectal cancer patients undergoing intersphincteric resection after neoadjuvant chemoradiation.
    Lee SY; Jo JS; Kim HJ; Kim CH; Kim YJ; Kim HR
    J Surg Oncol; 2015 Jun; 111(8):1054-8. PubMed ID: 25977149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of distribution of lymph node metastasis in advanced mid or low rectal cancer.
    Kim JS; Sohn DK; Park JW; Kim DY; Chang HJ; Choi HS; Oh JH
    J Surg Oncol; 2011 Oct; 104(5):486-92. PubMed ID: 21538360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
    Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
    J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
    Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.
    Fernández-Aceñero MJ; Granja M; Sastre J; García-Paredes B; Estrada L
    Virchows Arch; 2016 Apr; 468(4):425-30. PubMed ID: 26754675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
    Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
    Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection.
    Lee SD; Kim TH; Kim DY; Baek JY; Kim SY; Chang HJ; Park SC; Park JW; Oh JH; Jung KH
    Eur J Surg Oncol; 2012 Jun; 38(6):478-83. PubMed ID: 22465588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup.
    Sprenger T; Rothe H; Conradi LC; Beissbarth T; Kauffels A; Kitz J; Homayounfar K; Wolff H; Ströbel P; Ghadimi M; Wittekind C; Sauer R; Rödel C; Liersch T
    Dis Colon Rectum; 2016 May; 59(5):377-85. PubMed ID: 27050599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymph node dissection after primary surgery and neoadjuvant radiochemotherapy of rectal cancer. Interim analysis of a multicenter prospective observational study (OCUM)].
    Kreis ME; Maurer CA; Ruppert R; Ptok H; Strassburg J; Junginger T; Merkel S; Hermanek P
    Chirurg; 2015 Dec; 86(12):1132-7. PubMed ID: 26223668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer.
    Persiani R; Biondi A; Gambacorta MA; Bertucci Zoccali M; Vecchio FM; Tufo A; Coco C; Valentini V; Doglietto GB; D'Ugo D
    Br J Surg; 2014 Jan; 101(2):133-42. PubMed ID: 24375303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.